Amicus Therapeutics CEO John Crowley

In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic. Learn more about your ad choices. Visit megaphone.fm/adchoices